Answers are grounded in this paper and cite their sources.
In biomedical research, particularly for rare diseases (RDs), there is a critical need for model organisms to unravel the mechanistic basis of diseases, perform biomarker studies and develop potential therapeutic interventions. Within Solve-RD, an EU-funded research project with the aim of solving large numbers of previously unsolved RDs, the European Rare Disease Models & Mechanisms Network (RDMM-Europe) has been established.
No takes yet. Share an insight, caveat, or question.
Ellwanger et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: